The global monoclonal antibody diagnostic reagent market is poised for significant expansion, driven by the increasing demand for precise and early disease detection solutions. According to The Insight Partners, the market is projected to grow from US$ 12.82 billion in 2025 to US$ 41.02 billion by 2034 , registering a robust CAGR of 13.79% during 2026–2034 . This strong growth trajectory...